Strategic Intelligence: Big Data in Pharma

Strategic Intelligence: Big Data in Pharma



Summary

Big data is generated extensively across pharma

The international pharmaceutical landscape generates vast amounts of data from a variety of sources, such as patient registries, clinical trials, wearable technologies, and more. Such datasets are extremely vast, complex, and unstructured, rendering traditional big data analytical methodologies inefficient for processing.

As a result, organizations within the pharmaceutical industry are innovating big data analytical technologies that can secure, store, process, analyze, aggregate, and integrate vast and complex datasets for the purpose of acquiring novel insights. Furthermore, these technologies can be implemented with machine learning (ML), artificial intelligence (AI), Internet of Things (IoT), digital twins, and more.

This report consolidates GlobalData’s latest thinking and forecasts around how the healthcare, macroeconomic, technology, and regulatory trends will impact the big data in pharma space, as well as providing insights into the leading players and future disruptors across the value chain, and providing insights into key drugs and markets from GlobalData’s Pharma Intelligence Center. Additionally, this report is designed to provide strategic planners, competitive intelligence professionals and key stakeholders in the pharmaceutical industry a clear view of the opportunities and risks over the foreseeable future for big data.

Scope
  • A dedicated report examining the pivotal healthcare, technological, macroeconomic, and regulatory trends shaping the big data in pharma landscape. This report also provides an in-depth analysis of how these trends are poised to either accelerate progress or create obstacles for the growth of the big data market.
Reasons to Buy
  • Understand the key trends accelerating or hindering the big data in pharma space.
  • See market forecasts for different therapies within big data up to 2028.
  • Understand recent and influential developments in big data.
  • Review of leaders and disruptors across the big data value chain.


  • Executive Summary
  • Players
    • Table Figure 1: Who are the leading players in the big data pharma space?
  • Thematic Briefing
  • Trends
    • Healthcare trends
      • Table Healthcare trends in the big data space
    • Technology trends
      • Table Technology trends in the big data space
    • Macroeconomic trends
      • Table Macroeconomic trends in the big data space
    • Regulatory trends
      • Table Regulatory trends in the big data space
  • Industry Analysis
    • Market forecast size
      • Table Figure 2: Pharma contributed 1.1% of the total global data and analytics market in 2022
      • Table Figure 3: Pharma will contribute 1.1% of the total global data and analytics market in 2028
      • Table Figure 4: The total global data and analytics market for pharma was valued at $1.1B in 2022, led by China
      • Table Figure 5: China will lead the global data and analytics market in pharma in 2028
    • Survey data
      • GlobalData's surveys on big data's impact on the pharma industry and key pharma benefit, 2024
        • Table Figure 6: Confidence levels in big data's potential to transform the pharmaceutical industry
        • Table Figure 7: Key pharmaceutical value chain components poised to benefit most from big data
    • Pharma case studies
      • DNAnexus collaborates with multiple companies to enhance innovation within drug discovery
      • Johnson & Johnson MedTech announces data- and AI-driven solutions to accelerate the surgical landscape
      • Dotmatics launches cloud data platforms to optimize workflow for complex bioinformatics datasets
      • Parexel and Palantir collaborate to improve the quality of patient care
      • Ribbon Health announces its provider data platform to accelerate the healthcare data management landscape
      • NovAccess collaborates with CKN Ventures to utilize big data and AI for personalized healthcare
  • Signals
    • M&A trends
      • Table Examples of M&A in the big data and pharma spaces, 2022-24
    • Strategic partnerships
      • Table Examples of strategic partnerships in the pharma big data space, 2022-24
    • Funding deals
      • Table Examples of large funding deals in the big data space since 2022
    • Social media influencers
      • Table Figure 8: Big data trends in GlobalData's social media analytics database, September 2023 - September 2024
      • Table Figure 9: Examples of top posts related to big data, 2023-24
  • Value Chain
    • Table Figure 10: The big data value chain in pharma
    • Big data generation
    • Big data management
    • Big data product development
      • Drug target discovery
        • Table Drug target discovery big data analytical tools
      • Virtual clinical trials
        • Table VCT big data analytical tools
      • Precision medicine
        • Table Precision medicine big data analytical tools
      • Digital twins
        • Table Digital twins big data analytical tools
      • Telemedicine
        • Table Telemedicine big data analytical tools
      • Digital biomarkers
        • Table Digital biomarkers big data analytical tools
      • Wearable tech
      • Genomics
        • Table Genomics integration within the big data space
      • Commercial (marketing & sales)
  • Companies
    • Leading big data vendors
      • Table Examples of leading big data vendors within the big data theme
    • Specialist big data vendors in pharma
      • Table Examples of specialist big data vendors in the big data theme
    • Leading big data adopters in pharma
      • Table Examples of leading big data adopters in the big data theme
  • Sector Scorecards
    • Drug manufacturing sector scorecard
      • Who's who
        • Table Figure 11: Who does what in the drug manufacturing space?
      • Thematic screen
        • Table Figure 12: Our thematic screen ranks companies based on overall leadership in the 10 themes that matter most to their industry, generating a leading indicator of future performance
      • Valuation screen
        • Table Figure 13: Our valuation screen ranks our universe of companies within a sector based on selected valuation metrics
      • Risk screen
        • Table Figure 14: Our risk screen ranks companies within a particular sector based on overall investment risk
  • Bibliography
  • Appendix
    • Abbreviations
  • Further Reading
    • GlobalData reports
      • Table GlobalData reports
  • Our Thematic Research Methodology

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings